Interview

#AI / data analytics / healthtech / informatics #Alzheimer's #CNS #Gene editing #Human disease models #Interview #Neurodegenerative disorders #Neurology #Neuropsychiatric disorders #Neuroscience #Precision medicine #PrecisionLife #Stem cells

Podcast: Unlocking neuroscience drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovative uses for biomarkers in drug discovery”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “Advances in neuroscience drug discovery”, “Putting human data at the centre of… Read More

#News

#Career #Drug discovery #Interview #Meet the Researcher

Meet the researcher: Duncan McHale, Persica Pharmaceuticals

DDW’s Megan Thomas examines the work of Dr Duncan McHale, Chief Medical Officer at Persica Pharmaceuticals. MT: Can you tell us what you do and what you’re working on at the moment? DM:  In 2017, I founded an early drug development consultancy called Weatherden with Houman Ashrafian and Emma… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Cancer research #Drug discovery #Emulate #Gene expression #Gene therapy #Interview #Metabolomics #Multi-omics #Next generation sequencing #NGS #Omics #Organ-on-a-chip #Personalised medicine #Preclinical investigations #Spatial biology

Podcast: Cutting-edge tools shaping early-stage drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Cutting-edge tools shaping early-stage drug discovery”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “The use-case for NGS”, “Are organ-chips the future of preclinical… Read More

#News

Neural networks
#Artificial intelligence (AI) #Deep learning #Drug discovery #Interview

How neural networks can advance AI in drug discovery

DDW Editor Reece Armstrong speaks to Adityo Prakash, CEO of Verseon, about AI and deep learning in drug discovery and how neural networks within AI are influencing drug discovery approaches. RA: Could you explain the architectural differences between Verseon’s VersAI’s neural network and deep learning neural networks? AP: The underlying… Read More

#Exclusive Content

#Artificial intelligence (AI) #Clinical trial design #Deep learning #Fibrosis #Imaging #Interview

How is deep learning imaging advancing drug discovery for fibrosis?

Diana Spencer speaks to Dr Muhunthan Thillai, CEO at Qureight, about the company’s AI-powered imaging analytics and the technology’s potential in lung diseases and beyond.  DS: Can you provide some background to the company? MT: We are a core imaging laboratory using deep-learning and analytics… Read More

#Exclusive Content

Gold compound
#Alzheimer's #BioInnovation Institute #Biotech hubs #Cognition Therapeutics #India #Interview #Market reporting #Neurodegenerative disorders #Neuroscience #Pregnancy #Start-ups #Women's health

Podcast: Where are scientists making waves in drug discovery?

This is the latest episode of the free DDW narrated podcast, titled “Where are scientists making waves in drug discovery?”, which covers three articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “How pharma is targeting advances in Alzheimer’s treatments”, “The start-up disrupting… Read More

#News

#Endometriosis #Interview #Women's health

The drug discovery challenges facing endometriosis

DDW Editor Reece Armstrong speaks to Dr Piraye Yurttas Beim about the unmet need for patients with endometriosis and how research could lead to new treatments for ovarian health. RA: What are the current unmet needs for women with endometriosis? PB: Endometriosis is an inflammatory pain condition estimated to impact more… Read More

#Exclusive Content

Scientist pipetting in the lab
#Cellular assays #Drug discovery #Interview #Screening #Spinout #Turning Science into Business

Turning science into business: A step-change in adherent cell-based assays

Semarion was voted one of the SLAS2025 New Product Award winners. DDW’s Diana Spencer catches up with CEO and Co-founder Jeroen Verheyen to find out how the company has bridged the worlds of science and engineering.  DS: Congratulations on being one of the SLAS2025 New Product Award winners. Read More

#Business & Investment #Exclusive Content

Meet The Exhibitor
#AI / data analytics / healthtech / informatics #Antibodies #Cancer research #Career #From the top #Genetics / genomics #Interview #Meet the Researcher #Oncology #Research and development #Sitting Down With #Women in STEM

New podcast: Getting to know key drug discovery leaders

This is the latest episode of the free DDW narrated podcast, titled “Getting to know key drug discovery leaders”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Sitting down with… Neil Dhawan”, “Meet the researcher: Giusy Di Conza, iOnctura”… Read More

#News

#Cell line development #Cell lines #Drug discovery #Interview

Addressing the growing demand for new treatments with cell lines

Dr James Taylor, Senior Scientist in Cell Line Development at Samsung Biologics, speaks with DDW’s Megan Thomas about how to address the challenges in meeting complex molecule requirements, regulatory standards, and environmental sustainability. Benefits for developers  The biopharmaceutical industry has seen a surge in demand for drugs that treat… Read More

#Exclusive Content

CAR-T in multiple myeloma
#CAR-T #Cell therapy #Interview #Kite Pharma #Oncology

CAR-T cell therapy: Overcoming critical infrastructure challenges 

DDW’s Diana Spencer speaks to Dan Tovar, Senior Director, Head of Cell Therapy ACE Midsize Markets, Medical Affairs at Kite Pharma, about the current landscape for cell therapies and what can be done to improve patient access.  DS: Kite has pioneered cell therapy, with Yescarta (axicabtagene ciloleucel) as… Read More

#Business & Investment #Cancer Research #Exclusive Content

#Cell line development #Cell lines #Drug discovery #Interview #Tune Therapeutics

Innovating biopharmaceuticals: The benefits of cell line development

DDW’s Megan Thomas speaks to Dr Lucas Thompson, Senior Director of Research at Tune Therapeutics, about the advancements in cell line development and how biotechnologies can enhance the precision and efficiency of therapeutic protein production. MT: What are the benefits cell line development is bringing to biopharmaceutical developers? LT: For… Read More

#Exclusive Content

#Drug development #Drug discovery #Interview #NanoTemper Technologies #Sitting Down With #Vodcast

New vodcast: Sitting Down With… Philipp Baaske, NanoTemper

DDW’s Megan Thomas caught up with Philipp Baaske, Co-Founder & Executive Chairman of NanoTemper Technologies, about biophysical characterisation techniques for complex biologics. Highlights of the Vodcast As drug discovery moves beyond traditional small molecules, biophysical characterisation techniques must evolve to keep pace with the increasing complexity of new drug… Read More

#News

Strand of RNA
#Interview #Manufacturing #mRNA #Nanopore sequencing #Sitting Down With podcast

Podcast: Unveiling the role of mRNA analytics in cGMP manufacturing

A new sponsored DDW Sitting Down With podcast is now available. In this podcast, Megan Thomas speaks to experts from Lonza and Oxford Nanopore about their collaboration to bring direct mRNA sequencing (including N1-Methyl-pseudouridine) to a regulated environment and establish the new gold standard in sequencing technology. Read More

#News